Stockscreener 앱 받기
1.76
2.76%
-0.05
시간 외 거래:
1.77
0.01
+0.57%
Psyence Biomedical Ltd 주식(PBM)의 최신 뉴스
Bull Run: Why Psyence Biomedical Ltd stock appeals to dividend seekersTrade Performance Summary & Long-Term Growth Portfolio Plans - BỘ NỘI VỤ
How Psyence Biomedical Ltd. Equity Warrant stock benefits from global expansionJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
Will Psyence Biomedical Ltd. Equity Warrant stock remain a Wall Street favoriteWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Will Psyence Biomedical Ltd. Equity Warrant stock sustain high P E ratiosAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser
Is Psyence Biomedical Ltd. stock attractive for growth ETFsPortfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Price to earnings ratio of Psyence Biomedical Ltd. Warrant 20242028 on Psyence Biomedical – NASDAQ:PBMWW - TradingView
Psyence Biomedical (PBM) Stock Analysis Report | Financials & Insights - Benzinga
Psyence Biomedical (NASDAQ:PBM) Trading Down 2.5% – Should You Sell? - Defense World
Psyence Biomedical Ltd. (PBM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Psyence Biomedical : The Future of Human Longevity Will Be Transformational – And Nature May Hold the Key - marketscreener.com
How geopolitical tensions affect Psyence Biomedical Ltd. stockWeekly Trade Report & Safe Capital Growth Tips - BỘ NỘI VỤ
Psyence BioMed leads longevity research on psilocybin - Longevity.Technology
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Spike Watch & Reliable Breakout Forecasts - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Psyence Biomedical Ltd - Setenews
Breakout Move: Why Psyence Biomedical Ltd. Equity Warrant stock is popular among millennialsEntry Point & Safe Capital Growth Stock Tips - BỘ NỘI VỤ
Psyence Biomedical launches psilocybin longevity research program By Investing.com - Investing.com Nigeria
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program - Asianet Newsable
Psyence Biomedical launches psilocybin longevity research program - Investing.com
Psyence BioMed (Nasdaq: PBM) Starts First Psilocybin Longevity Biomarker Study - Stock Titan
Psyence BioMed Expands Ibogaine Operations in Africa with Strategic Investment - MSN
Psyence Biomedical Ltd. (PBM) -13.37% in Normal Trading: Decline Amid Recent Breakthrough Announcement - Stocks Telegraph
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
[6-K] PSYENCE BIOMEDICAL LTD. Current Report (Foreign Issuer) | PBM SEC FilingForm 6-K - Stock Titan
Psyence Biomedical Reports Strong Financial Growth in Latest Interim Results - MSN
Will Psyence Biomedical Ltd. stock rally after Fed decisionsPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com
Is Psyence Biomedical Ltd. stock in correction or buying zoneWeekly Trading Summary & Weekly Setup with ROI Potential - newser.com
The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews
How Psyence Biomedical Ltd. Equity Warrant stock reacts to job market dataJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com
Psyence BioMed secures sustainable iboga supply for clinical research By Investing.com - Investing.com Nigeria
[424B3] PSYENCE BIOMEDICAL LTD. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Is PBM’s Market Boost a Fleeting Mirage? - StocksToTrade
Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025 - ts2.tech
Is It Time to Buy PBM Stock? - timothysykes.com
Psyence BioMed secures sustainable iboga supply for clinical research - Investing.com
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets - The Manila Times
Psyence BioMed Reaches Major Breakthrough in - GlobeNewswire
Institutional scanner results for Psyence Biomedical Ltd. Equity WarrantMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Can Psyence Biomedical Ltd. Equity Warrant recover in the next quarterWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Candlestick signals on Psyence Biomedical Ltd. Equity Warrant stock todayJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Applying Elliott Wave Theory to Psyence Biomedical Ltd.Weekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
Psyence Biomedical Ltd. recovery potential after sell offPortfolio Performance Summary & Free Long-Term Investment Growth Plans - newser.com
Will Psyence Biomedical Ltd. Equity Warrant stock benefit from automationPortfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Can Psyence Biomedical Ltd. stock deliver sustainable ROETrade Risk Summary & Community Shared Stock Ideas - newser.com
What momentum indicators show for Psyence Biomedical Ltd. stock2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
1.44%
0.91%
자본화:
|
볼륨(24시간):